Retrovirology

official impact factor 5.24
Search for
Advanced search
Retrovirology
Tools

This article is part of the supplement: AIDS Vaccine 2009

Open Access Oral presentation

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

B Jacobs1*, K Kibler1, S Wong1, T Huynh1, S Holechek1, K Denzler1, W Arndt1, M Parrington2, J Tartaglia2 and G Pantaleo3

  • * Corresponding author: B Jacobs

Author Affiliations

1 The Biodesign Institute, CIDV, Arizona State University, Tempe, AZ, USA

2 Sanofi-Pasteur, Toronto, Canada

3 CHUV, Lausanne, Switzerland

For all author emails, please log on.

Retrovirology 2009, 6(Suppl 3):O13 doi:10.1186/1742-4690-6-S3-O13

Published: 22 October 2009

First paragraph (this article has no abstract)

Poxvirus viruses have been utilized for many years as vaccine vectors. Recent years have seen an increase in efforts to identify safer pox vectors to express heterologous antigens, in this case HIV antigens.